SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/335062"
 

Search: onr:"swepub:oai:gup.ub.gu.se/335062" > A blood-based multi...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groups

Jiang, Yuanbing (author)
Uhm, Hyebin (author)
Ip, Fanny C. (author)
show more...
Ouyang, Li (author)
Lo, Ronnie M.N. (author)
Cheng, Elaine Y.L. (author)
Cao, Xiaoyun (author)
Tan, Clara M.C. (author)
Law, Brian C.H. (author)
Ortiz-Romero, Paula (author)
Puig-Pijoan, Albert (author)
Fernández-Lebrero, Aida (author)
Contador, José (author)
Mok, Kin Y. (author)
Hardy, John (author)
Kwok, Timothy C.Y. (author)
Mok, Vincent C.T. (author)
Suárez-Calvet, Marc (author)
Zetterberg, Henrik, 1973 (author)
Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Fu, Amy K.Y. (author)
Ip, Nancy Y. (author)
show less...
 (creator_code:org_t)
2024
2024
English.
In: Alzheimer's and Dementia. - 1552-5260 .- 1552-5279.
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • INTRODUCTION: Existing blood-based biomarkers for Alzheimer's disease (AD) mainly focus on its pathological features. However, studies on blood-based biomarkers associated with other biological processes for a comprehensive evaluation of AD status are limited. METHODS: We developed a blood-based, multiplex biomarker assay for AD that measures the levels of 21 proteins involved in multiple biological pathways. We evaluated the assay's performance for classifying AD and indicating AD-related endophenotypes in three independent cohorts from Chinese or European-descent populations. RESULTS: The 21-protein assay accurately classified AD (area under the receiver operating characteristic curve [AUC]=0.9407 to 0.9867) and mild cognitive impairment (MCI; AUC=0.8434 to 0.8945) while also indicating brain amyloid pathology. Moreover, the assay simultaneously evaluated the changes of five biological processes in individuals and revealed the ethnic-specific dysregulations of biological processes upon AD progression. DISCUSSION: This study demonstrated the utility of a blood-based, multi-pathway biomarker assay for early screening and staging of AD, providing insights for patient stratification and precision medicine. HIGHLIGHTS: The authors developed a blood-based biomarker assay for Alzheimer's disease. The 21-protein assay classifies AD/MCI and indicates brain amyloid pathology. The 21-protein assay can simultaneously assess activities of five biological processes. Ethnic-specific dysregulations of biological processes in AD were revealed.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Neurosciences (hsv//eng)

Keyword

Alzheimer's disease
amyloid pathology
blood biomarkers
disease staging
early detection
patient stratification
precision medicine

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view